# Galderma receives license for new toxin manufacturing facility in Uppsala

Galderma received a manufacturing license from the Swedish Medical Products Agency for a new state-of-the-art facility at its Center of Excellence in Uppsala, Sweden, to produce its QM1114 liquid botulinum toxin.

- Type: New facility
- Announced: 2019-11-05
- Where: Uppsala, Sweden, Sweden
- Status: announced
- Products: botulinum toxin type A (QM1114 liquid formulation)
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Galderma](https://endata.com/companies/43138.md)

## Sources

- [aestheticsjournal.com](https://aestheticsjournal.com/news/galderma-to-open-new-toxin-manufacturing-facility/), 2019-11-05: "Galderma has received a manufacturing license from the Swedish Medical Products Agency (MPA) for a new state-of-the-art manufacturing facility at the Center of Excellence, located in Uppsala, Sweden."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.